share_log

Bruush Oral Care | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Bruush Oral Care | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Bruush Oral Care | 6-K：外國發行人報告
美股SEC公告 ·  03/02 06:20
牛牛AI助理已提取核心訊息
Bruush Oral Care Inc. has been notified by the Nasdaq Listing Qualifications Department that it no longer meets the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company's common shares have not maintained the required $1.00 per share minimum bid price for 30 consecutive trading days, as stipulated by Nasdaq Listing Rule 5550(a)(2). Bruush Oral Care was given until May 13, 2024, to regain compliance. However, the situation worsened when the company's shares closed at $0.10 or less for ten consecutive trading days, violating the Nasdaq's Low Priced Stocks Rule. Consequently, Nasdaq has decided to delist Bruush Oral Care's securities, with trading suspension set to commence on March 7, 2024, unless the company appeals by March 5, 2024. Bruush Oral Care has requested a hearing before the Nasdaq Hearings Panel, which is scheduled for April 25, 2024, where the company will present a plan to regain compliance. The outcome of the hearing and the company's ability to meet Nasdaq's continued listing requirements remain uncertain.
Bruush Oral Care Inc. has been notified by the Nasdaq Listing Qualifications Department that it no longer meets the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company's common shares have not maintained the required $1.00 per share minimum bid price for 30 consecutive trading days, as stipulated by Nasdaq Listing Rule 5550(a)(2). Bruush Oral Care was given until May 13, 2024, to regain compliance. However, the situation worsened when the company's shares closed at $0.10 or less for ten consecutive trading days, violating the Nasdaq's Low Priced Stocks Rule. Consequently, Nasdaq has decided to delist Bruush Oral Care's securities, with trading suspension set to commence on March 7, 2024, unless the company appeals by March 5, 2024. Bruush Oral Care has requested a hearing before the Nasdaq Hearings Panel, which is scheduled for April 25, 2024, where the company will present a plan to regain compliance. The outcome of the hearing and the company's ability to meet Nasdaq's continued listing requirements remain uncertain.
Bruush口腔護理公司收到納斯達克上市資格部門的通知，稱其不再滿足納斯達克資本市場繼續上市的最低買盤價格要求。公司普通股未能維持納斯達克上市規則5550(a)(2)規定的30個連續交易日要求的每股最低買盤價爲1.00美元。Bruush口腔護理公司獲得了直到2024年5月13日恢復合規的時間，但情況惡化到該公司的股票在連續10個交易日內收盤價爲0.10美元或更低，違反了納斯達克的低價股票規則。因此，納斯達克決定將Bruush口腔護理公司的證券退市，交易停牌將於2024年3月7日開始，除非該公司在2024年3月5日前上訴。Bruush口腔護理公司已要求在2024年4月25日納斯達克聽證會前進行聽證，屆時公司將提出恢復合規的計劃。聽證的結果和公司滿足納斯達克繼續上市要求的能力仍然不確定。
Bruush口腔護理公司收到納斯達克上市資格部門的通知，稱其不再滿足納斯達克資本市場繼續上市的最低買盤價格要求。公司普通股未能維持納斯達克上市規則5550(a)(2)規定的30個連續交易日要求的每股最低買盤價爲1.00美元。Bruush口腔護理公司獲得了直到2024年5月13日恢復合規的時間，但情況惡化到該公司的股票在連續10個交易日內收盤價爲0.10美元或更低，違反了納斯達克的低價股票規則。因此，納斯達克決定將Bruush口腔護理公司的證券退市，交易停牌將於2024年3月7日開始，除非該公司在2024年3月5日前上訴。Bruush口腔護理公司已要求在2024年4月25日納斯達克聽證會前進行聽證，屆時公司將提出恢復合規的計劃。聽證的結果和公司滿足納斯達克繼續上市要求的能力仍然不確定。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。